Acutaas Chemicals: Strong Earnings, Driven by CDMO Mix
Moneylife Digital Team 07 May 2026
Acutaas Chemicals Limited (Acutaas) makes advanced pharmaceutical intermediates (APIs) and specialty chemicals. Under its API segment, it manufactures molecules that are under clinical trial or...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Laurus Labs Accelerates Transformation on Strong CDMO Execution
Moneylife Digital Team 07 May 2026
Laurus Labs (Laurus), a Hyderabad-based pharma major, delivered a materially stronger FY25-26, driven by its growing contract development and manufacturing organisation (CDMO) business and a resilient generics portfolio. Established...
Waaree Renewable: Growth Story Faces Grid and Order-book Constraints
Moneylife Digital Team 05 May 2026
Waaree Renewable Technologies (Waaree Renewable), a subsidiary of Waaree Energies and part of the Waaree group, reported a 66% year-on-year (y-o-y) surge in net profit for Q4FY25-26, driven by India's accelerating solar sector growth....
JNK India: Order-book Visibility, Joint Venture Optionality
Moneylife Digital Team 05 May 2026
JNK India Limited (JNK India) is a Mumbai-based technology-driven EPC (engineering-procurement-construction) company incorporated in 2010, specialising in combustion equipment for the oil, gas, petrochemicals and fertiliser...
Amanta Healthcare Expands Capacity, Targets Higher Profitability
Moneylife Digital Team 05 May 2026
Amanta Healthcare Limited (Amanta) operates within the niche sterile liquid pharmaceuticals segment, primarily supplying hospitals and institutional clients across domestic and export markets. Historically, the investment thesis has...
Free Helpline
Legal Credit
Feedback